generated: '2026-09-06' method: probed source: https://www.actymthera.com/_api/mcp summary: >- Actym Therapeutics publishes no OpenAPI, AsyncAPI, GraphQL SDL or industry data contract. The only machine-readable surfaces it serves are two agent-facing conventions: an llms.txt and a Model Context Protocol endpoint, both delivered by the Wix platform on Actym's own domain. No domain standard for the biotech / clinical-research market (HL7 FHIR, CDISC, ICH E2B, SPL) is declared or implemented anywhere on the surface. conformance: - id: mcp name: Model Context Protocol version: '2025-06-18' conforms: true evidence: >- POST https://www.actymthera.com/_api/mcp {"jsonrpc":"2.0","method":"initialize"} returned HTTP 200 with protocolVersion "2025-06-18" and a tools capability; tools/list returned 9 tools with inputSchema. Saved verbatim to mcp/actym-therapeutics-tools-list.json. - id: json-rpc-2.0 name: JSON-RPC 2.0 conforms: true evidence: >- The MCP endpoint answers JSON-RPC 2.0 envelopes (jsonrpc/id/result) — observed 2026-09-06. - id: llms-txt name: llms.txt conforms: true evidence: 'GET https://www.actymthera.com/llms.txt -> HTTP 200, text/plain, 3,262 bytes.' - id: robots-txt name: robots.txt (RFC 9309) conforms: true evidence: 'GET https://www.actymthera.com/robots.txt -> HTTP 200 with a Sitemap directive.' - id: sitemap-xml name: sitemaps.org XML sitemap conforms: true evidence: 'GET https://www.actymthera.com/sitemap.xml -> HTTP 200, sitemapindex with 4 child sitemaps.' - id: oauth2 name: OAuth 2.0 conforms: false evidence: 'No /.well-known/oauth-authorization-server or /.well-known/oauth-protected-resource (HTTP 400 on both hosts). The MCP endpoint is anonymous.' - id: openapi name: OpenAPI conforms: false evidence: 'No OpenAPI at any probed path on www.actymthera.com or actymthera.com (400/404).' - id: rfc9457 name: RFC 9457 Problem Details conforms: false evidence: 'No error contract published; no API with a documented error envelope.' domain_standard: applicable: true sector: biotechnology / clinical-stage pharmaceuticals declared: false evidence: >- No HL7 FHIR, CDISC SDTM/ODM, ICH E2B, SPL or comparable life-sciences data standard is named or implemented on any Actym surface. Actym is a clinical-stage drug developer with a six-page marketing site and no data-exchange product, so no domain standard applies to a contract it does not publish. Reward-only: recorded as absent, not as a failure. certifications: [] notes: - Nothing here is a compliance certification, so no `Compliance` pointer is emitted.